Filter By Industry
Filter By Tag

Newsroom

VLN Biotechnology Press releases

1 - 3 of 3 Press Releases

VLN Biotechnology Hires Dr. Paul O’Reilly from the University of Ottawa
Jul 08, 2014
VLN Biotechnology - a Company focused on development of immunotherapy against the common allergenic molds Alternaria & Cladosporium

Dr. H. Vijay of VLN Biotechnology Contributes to 5th Edition of Allergens and Allergy Immunotherapy
Jun 09, 2014
VLN Biotechnology - a Company focused on development of immunotherapy against the common allergenic molds Alternaria & Cladosporium

VLN Biotechnology Announces New Facilities
Dec 03, 2013
A Company focused on development of immunotherapy against common allergenic molds such as Alternaria & Cladosporium


VLN Biotechnology RSS Feed